Dexcom (DXCM) Payables (2010 - 2026)

Dexcom (DXCM) has 17 years of Payables data on file, last reported at $2.1 billion in Q1 2026.

• Payables for Q1 2026 came in at $2.1 billion, down 28.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.1 billion (down 28.38% YoY), and the FY2025 annual result was $1.9 billion, down 30.31% from the prior year.
• Payables grew to $2.1 billion in Q1 2026 per DXCM's latest filing, from $1.9 billion in the prior quarter.
• Over five years, Payables peaked at $3.1 billion in Q2 2025 and troughed at $603.1 million in Q1 2022.
• A 5-year average of $1.8 billion and a median of $1.7 billion in 2022 frame the typical range for Payables.
• The sharpest annual moves came in 2022 and 2025: Payables jumped 192.22% in 2022, then plunged 30.31% in 2025.
• A 5-year view of Payables shows it stood at $1.7 billion in 2022, then dropped by 19.64% to $1.3 billion in 2023, then jumped by 107.32% to $2.8 billion in 2024, then sank by 30.31% to $1.9 billion in 2025, then climbed by 6.68% to $2.1 billion in 2026.
• Business Quant data shows DXCM's Payables at $2.1 billion in Q1 2026, $1.9 billion in Q4 2025, and $3.1 billion in Q3 2025.